Literature DB >> 27826709

Risk Factors for Cardiac Arrest or Mechanical Circulatory Support in Children with Fulminant Myocarditis.

Joseph R Casadonte1, Mjaye L Mazwi1,2, Katheryn E Gambetta1, Hannah L Palac3, Mary E McBride1,2, Osama M Eltayeb4, Michael C Monge4, Carl L Backer4, John M Costello5,6.   

Abstract

In children with fulminant myocarditis (FM), we sought to describe presenting characteristics and clinical outcomes, and identify risk factors for cardiac arrest and mechanical circulatory support (MCS). A retrospective review of patients with FM admitted at our institution between January 1, 2004, and June 31, 2015, was performed. We compared characteristics and outcomes of FM patients who received cardiopulmonary resuscitation (CPR) and/or were placed on MCS (CPR/MCS group) to those who did not develop these outcomes (Control group). There were 28 patients who met criteria for FM. Median age was 1.2 years (1 day-17 years). Recovery of myocardial function occurred in 13 patients (46%); 6 (21%) had chronic ventricular dysfunction, 6 (21%) underwent heart transplantation, and 3 (11%) died prior to hospital discharge (including one death following heart transplant). Of the 28 FM patients, 13 (46%) developed cardiac arrest (n = 11) and/or received MCS (n = 8). When compared to controls, patients in the CPR/MCS group had a higher peak b-type natriuretic peptide (BNP) levels (p = 0.03) and peak inotropic scores (p = 0.02). No significant differences were found between groups in demographics; chest radiograph, electrocardiogram, or echocardiogram findings; or initial laboratory values including BNP, troponin, C-reactive protein, lactate, and creatinine (p > 0.05 for all). Children with FM are at high risk of cardiovascular collapse leading to the use of CPR or MCS. Aside from peak BNP levels and inotropic scores, the most presenting characteristics were not helpful for predicting these outcomes. FM patients should ideally receive care in centers that provide emergent MCS.

Entities:  

Keywords:  Children; Extracorporeal membrane oxygenation; Fulminant myocarditis; Inotropic score; Viral myocarditis

Mesh:

Year:  2016        PMID: 27826709     DOI: 10.1007/s00246-016-1493-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  15 in total

1.  In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis.

Authors:  Christina Y Miyake; Sarah A Teele; Liyuan Chen; Kara S Motonaga; Anne M Dubin; Sowmya Balasubramanian; Raymond R Balise; David N Rosenthal; Mark E Alexander; Edward P Walsh; Douglas Y Mah
Journal:  Am J Cardiol       Date:  2013-11-09       Impact factor: 2.778

2.  Management of suspected myocarditis during critical-care transport.

Authors:  Gerhard K Wolf; Michael A Frakes; Michael Gallagher; Catherine K Allan; Suzanne K Wedel
Journal:  Pediatr Emerg Care       Date:  2010-07       Impact factor: 1.454

3.  Favorable outcome of pediatric fulminant myocarditis supported by extracorporeal membranous oxygenation.

Authors:  Elhanan Nahum; Ovdi Dagan; Amiram Lev; Golan Shukrun; Gabriel Amir; George Frenkel; Jacob Katz; Berant Michel; Einat Birk
Journal:  Pediatr Cardiol       Date:  2010-08-24       Impact factor: 1.655

4.  Management and outcomes in pediatric patients presenting with acute fulminant myocarditis.

Authors:  Sarah A Teele; Catherine K Allan; Peter C Laussen; Jane W Newburger; Kimberlee Gauvreau; Ravi R Thiagarajan
Journal:  J Pediatr       Date:  2010-12-30       Impact factor: 4.406

5.  Parvovirus B19 myocarditis causes significant morbidity and mortality in children.

Authors:  Kimberly M Molina; Xiomara Garcia; Susan W Denfield; Yuxin Fan; William R Morrow; Jeffrey A Towbin; Elizabeth A Frazier; David P Nelson
Journal:  Pediatr Cardiol       Date:  2012-08-08       Impact factor: 1.655

6.  Outcome of acute fulminant myocarditis in children.

Authors:  N Amabile; A Fraisse; J Bouvenot; P Chetaille; C Ovaert
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

7.  Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry.

Authors:  Satish K Rajagopal; Christopher S Almond; Peter C Laussen; Peter T Rycus; David Wypij; Ravi R Thiagarajan
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

8.  Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest.

Authors:  G Wernovsky; D Wypij; R A Jonas; J E Mayer; F L Hanley; P R Hickey; A Z Walsh; A C Chang; A R Castañeda; J W Newburger; D L Wessel
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

9.  Parvovirus B19 infection mimicking acute myocardial infarction.

Authors:  Uwe Kühl; Matthias Pauschinger; Thomas Bock; Karin Klingel; C Peter Lothar Schwimmbeck; Bettina Seeberg; Lars Krautwurm; Wolfgang Poller; Heinz-Peter Schultheiss; Reinhard Kandolf
Journal:  Circulation       Date:  2003-08-18       Impact factor: 29.690

10.  Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation.

Authors:  Stephen B Freedman; J Kimberly Haladyn; Alejandro Floh; Joel A Kirsh; Glenn Taylor; Jennifer Thull-Freedman
Journal:  Pediatrics       Date:  2007-12       Impact factor: 7.124

View more
  9 in total

1.  Elevated Troponin in the First 72 h of Hospitalization for Pediatric Viral Myocarditis is Associated with ECMO: An Analysis of the PHIS+ Database.

Authors:  Arene Butto; Joseph W Rossano; Deipanjan Nandi; Chitra Ravishankar; Kimberly Y Lin; Matthew J O'Connor; Robert E Shaddy; Pirouz Shamszad
Journal:  Pediatr Cardiol       Date:  2018-04-13       Impact factor: 1.655

2.  Computational Identification of Ventricular Arrhythmia Risk in Pediatric Myocarditis.

Authors:  Mark J Cartoski; Plamen P Nikolov; Adityo Prakosa; Patrick M Boyle; Philip J Spevak; Natalia A Trayanova
Journal:  Pediatr Cardiol       Date:  2019-03-06       Impact factor: 1.655

3.  MicroRNA-381 protects myocardial cell function in children and mice with viral myocarditis via targeting cyclooxygenase-2 expression.

Authors:  Yong Zhang; Lingli Sun; Hui Sun; Zhongqin Yu; Xia Liu; Xia Luo; Cuifang Li; Dongming Sun; Tao Li
Journal:  Exp Ther Med       Date:  2018-04-20       Impact factor: 2.447

Review 4.  Pediatric Myocarditis: What Have We Learnt So Far?

Authors:  Elettra Pomiato; Marco Alfonso Perrone; Rosalinda Palmieri; Maria Giulia Gagliardi
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-03

5.  Analysis of clinical parameters and echocardiography as predictors of fatal pediatric myocarditis.

Authors:  Yi-Jung Chang; Hsiang-Ju Hsiao; Shao-Hsuan Hsia; Jainn-Jim Lin; Mao-Sheng Hwang; Hung-Tao Chung; Chyi-Liang Chen; Yhu-Chering Huang; Ming-Han Tsai
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

Review 6.  Cardiac Biomarkers in Pediatrics: An Undervalued Resource.

Authors:  Mary Kathryn Bohn; Shannon Steele; Alexandra Hall; Jasmin Poonia; Benjamin Jung; Khosrow Adeli
Journal:  Clin Chem       Date:  2021-07-06       Impact factor: 12.167

7.  Role of electrocardiograms in assessment of severity and analysis of the characteristics of ST elevation in acute myocarditis: A two-centre study.

Authors:  Jiaozhen Chen; Shouquan Chen; Zhangping Li; Peisen Zhou; Weijia Huang; Hete Wang; Jincun Shi; Yunchao Ni; Lili Lin; Yuanli Lei
Journal:  Exp Ther Med       Date:  2020-08-27       Impact factor: 2.447

Review 8.  Neonatal Cardiac ECMO in 2019 and Beyond.

Authors:  Peter Paul Roeleveld; Malaika Mendonca
Journal:  Front Pediatr       Date:  2019-08-21       Impact factor: 3.418

Review 9.  Extracorporeal Membrane Oxygenation in Congenital Heart Disease.

Authors:  Tanya Perry; Tyler Brown; Andrew Misfeldt; David Lehenbauer; David S Cooper
Journal:  Children (Basel)       Date:  2022-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.